Tumor Ablation Market Size & Forecast By Technology, By Treatment By Application And Trend Analysis From 2015 To 2022

  • ID: 3736934
  • Report
  • Region: Global
  • 87 pages
  • Grand View Research
1 of 3
Global tumor ablation market is expected to reach USD 1.5 billion by 2022. Rising prevalence of different forms of cancer and increasing technological advancements in the field of thermal ablation techniques are the most prominent drivers of the market.

Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry.

Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone.

In terms of technological advancement, companies such as SonaCare Medical are coupling ablation techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable physicians to enhance patient care experience, thereby promoting market growth.

The industry is also anticipated to witness mergers and joint collaborations as a tool to curb rising competition. For instance, Boston Scientific Corporation acquired C.R. Bard Electrophysiology, which led to a 48.0% hike in profit for the former company.

Further key findings from the study suggest:

Microwave ablation technology is expected to be the fastest growing segment over the forecast period at a CAGR of over 15.0%. Reduction in the procedure time and low cost for treatment are some of the attributes favoring growth.

In terms of treatment, surgical ablation is predicted to form the largest market by 2022 with about 35.0% share. Liver and lung cancer ablation require surgical procedures, and since these form the largest and fastest growing segments, they concomitantly propel surgical ablation growth.

Lung cancer forms the most lucrative market and is anticipated to be the fastest growing segment over the forecast period. By 2022, it is expected to contribute about 15.0% of the revenue share owing to its rising prevalence rate across the globe.

According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.

Major players of the market include HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To retain market leadership, players such as Medtronic are working towards acquiring other companies and expanding their portfolio. For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation System from Baylis Medical.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
2. Executive Summary
2.1. Tumor Ablation Devices Market- Industry Snapshot and Key Buying Criteria, 2014
3. Tumor Ablation Devices Industry Outlook
3.1. Tumor Ablation Devices Market Segmentation
3.2. Tumor Ablation Devices Market Size and Growth Prospects
3.3. Tumor Ablation Devices Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Industry Analysis - Porter's
3.5. Tumor Ablation Devices Market PESTEL Analysis, 2014
3.6. Competitive Landscape
4. Tumor Ablation Devices Technology Outlook
4.1. Tumor Ablation Devices Market Share By Technology, 2014 & 2022
4.2. Radiofrequency Ablation Devices
4.2.1. Radiofrequency Ablation Devices Market Estimates and Forecasts, 2015 - 2022
4.3. Microwave Ablation Devices
4.3.1. Tumor Ablation Devices Market Estimates and Forecasts, 2015 - 2022
4.4. Cryoablation Devices
4.4.1. Cryoablation Devices Market Estimates and Forecasts, 2015 - 2022
4.5. Other Ablation Devices
4.5.1. Other Ablation Devices Market Estimates and Forecasts, 2015 - 2022
5. Tumor Ablation Devices Treatment Outlook
5.1. Tumor Ablation Devices Market Share By Treatment, 2014 & 2022
5.2. Surgical Ablation
5.2.1. Surgical Ablation Market Estimates and Forecasts, 2015 - 2022
5.3. Laparoscopic Ablation
5.3.1. Laparoscopic Ablation Market Estimates and Forecasts, 2015 - 2022
5.4. Percutaneous Ablation
5.4.1. Percutaneous Ablation Market Estimates and Forecasts, 2015 - 2022
6. Tumor Ablation Devices Application Outlook
6.1. Tumor Ablation Devices Market Share By Application, 2014 & 2022
6.2. Liver Cancer
6.2.1. Liver Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
6.3. Breast Cancer
6.3.1. Breast Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
6.4. Lung Cancer
6.4.1. Lung Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
6.5. Prostrate Metastasis
6.5.1. Prostrate Metastasis Ablation Devices Market Estimates and Forecasts, 2015 - 2022
6.6. Other Cancer
6.6.1. Other Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
7. Tumor Ablation Devices Regional Outlook
7.1. Tumor Ablation Devices Market Share By Region, 2014 & 2022
7.2. North America
7.2.1. North America Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
7.2.1.1. U.S. Market Estimates and Forecasts
7.2.1.2. Canada Market Estimates and Forecasts
7.2.2. North America Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
7.2.2.1. U.S. Market Estimates and Forecasts
7.2.2.2. Canada Market Estimates and Forecasts
7.2.3. North America Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
7.2.3.1. U.S. Market Estimates and Forecasts
7.2.3.2. Canada Market Estimates and Forecasts
7.3. Europe
7.3.1. Europe Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
7.3.1.1. Germany Market Estimates and Forecasts
7.3.1.2. UK Market Estimates and Forecasts
7.3.2. Europe Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
7.3.2.1. Germany Market Estimates and Forecasts
7.3.2.2. UK Market Estimates and Forecasts
7.3.3. Europe Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
7.3.3.1. Germany Market Estimates and Forecasts
7.3.3.2. UK Market Estimates and Forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
7.4.1.1. Japan Market Estimates and Forecasts
7.4.1.2. China Market Estimates and Forecasts
7.4.2. Asia Pacific Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
7.4.2.1. Japan Market Estimates and Forecasts
7.4.2.2. China Market Estimates and Forecasts
7.4.3. Asia Pacific Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
7.4.3.1. Japan Market Estimates and Forecasts
7.4.3.2. China Market Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
7.5.1.1. Mexico Estimates and Forecasts
7.5.1.2. Brazil Estimates and Forecasts
7.5.2. Latin America Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
7.5.2.1. Mexico Estimates and Forecasts
7.5.2.2. Brazil Estimates and Forecasts
7.5.3. Latin America Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
7.5.3.1. Mexico Estimates and Forecasts
7.5.3.2. Brazil Estimates and Forecasts
7.6. MEA
7.6.1. MEA Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
7.6.1.1. South Africa Estimates and Forecasts
7.6.1.2. Saudi Arabia Estimates and Forecasts
7.6.2. MEA Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
7.6.2.1. South Africa Estimates and Forecasts
7.6.2.2. Saudi Arabia Estimates and Forecasts
7.6.3. MEA Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
7.6.3.1. South Africa Estimates and Forecasts
7.6.3.2. Saudi Arabia Estimates and Forecasts
8. Competitive Landscape
8.1. Medtronic Plc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Angiodynamics
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Mermaid Medical
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. HealthTronics
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Galil Medical Inc.
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. EDAP TMS S.A.
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Boston Scientific Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. SonaCare Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Misonix, Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Neuwave Medical, Inc.
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives

List of Tables

Table 1 Tumor ablation market - Industry Summary & Key Buying Criteria
Table 2 Tumor ablation market, by technology, 2015 - 2022 (USD million)
Table 3 Tumor ablation market, by treatment, 2015 - 2022 (USD million)
Table 4 Tumor ablation market, by application, 2015 - 2022 (USD million)
Table 5 Tumor ablation market, by region, 2015 - 2022 (USD Million)
Table 6 Tumor ablation - Key market driver analysis
Table 7 Tumor ablation - Key market restraint analysis
Table 8 North America tumor ablation market, by region 2015 - 2022 (USD Million)
Table 9 North America tumor ablation market, by technology2015 - 2022 (USD Million)
Table 10 North America tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 11 North America tumor ablation market, by application 2015 - 2022 (USD Million)
Table 12 U.S. tumor ablation market, by technology2015 - 2022 (USD Million)
Table 13 U.S. tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 14 U.S. tumor ablation market, by application 2015 - 2022 (USD Million)
Table 15 Canada Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 16 Canada Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 17 Canada tumor ablation market, by application 2015 - 2022 (USD Million)
Table 18 Europe tumor ablation market, by region 2015 - 2022 (USD Million)
Table 19 Europe tumor ablation market, by technology2015 - 2022 (USD Million)
Table 20 Europe tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 21 Europe tumor ablation market, by application 2015 - 2022 (USD Million)
Table 22 UK Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 23 UK Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 24 UK tumor ablation market, by application 2015 - 2022 (USD Million)
Table 25 Germany Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 26 Germany Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 27 Germany tumor ablation market, by application 2015 - 2022 (USD Million)
Table 28 Latin America tumor ablation market, by region 2015 - 2022 (USD Million)
Table 29 Latin America tumor ablation market, by technology2015 - 2022 (USD Million)
Table 30 Latin America tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 31 Latin America tumor ablation market, by application 2015 - 2022 (USD Million)
Table 32 Brazil Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 33 Brazil Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 34 Brazil tumor ablation market, by application 2015 - 2022 (USD Million)
Table 35 Mexico Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 36 Mexico Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 37 Mexico tumor ablation market, by application 2015 - 2022 (USD Million)
Table 38 MEA tumor ablation market, by region 2015 - 2022 (USD Million)
Table 39 MEA tumor ablation market, by technology2015 - 2022 (USD Million)
Table 40 MEA tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 41 MEA tumor ablation market, by application 2015 - 2022 (USD Million)
Table 42 South Africa Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 43 South Africa Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 44 South Africa tumor ablation market, by application 2015 - 2022 (USD Million)
Table 45 Saudi Arabia Tumor ablation market, by technology2015 - 2022 (USD Million)
Table 46 Saudi Arabia Tumor ablation market, by treatment 2015 - 2022 (USD Million)
Table 47 Saudi Arabia tumor ablation market, by application 2015 - 2022 (USD Million)

List of Figures

Figure 1 Global tumor ablation: Market segmentation
Figure 2 Global tumor ablation market, 2012 - 2020 (USD Million)
Figure 3 Tumor ablation: Market dynamics
Figure 4 Tumor ablation market - Porter’s analysis
Figure 5 Key opportunities prioritized
Figure 6 Tumor ablation market - PESTEL Analysis
Figure 7 Tumor ablation market share, by technology, 2013 & 2020
Figure 8 Radiofrequency ablation market, 2015 - 2022 (USD Million)
Figure 9 Microwave ablation market, 2015 - 2022 (USD Million)
Figure 10 Cryoablation market, 2015 - 2022 (USD Million)
Figure 11 Other ablation technology market, 2015 - 2022 (USD Million)
Figure 12 Tumor ablation market share, by treatment, 2013 & 2020
Figure 13 Surgical ablation market, 2015 - 2022 (USD Million)
Figure 14 Laparoscopic ablation market, 2015 - 2022 (USD Million)
Figure 15 Percutaneous ablation market, 2015 - 2022 (USD Million)
Figure 16 Tumor ablation market by application, 2015 - 2022 (USD Million)
Figure 17 Liver cancer market, 2015 - 2022 (USD Million)
Figure 18 Breast cancer market, 2015 - 2022 (USD Million)
Figure 19 Lung cancer market, 2015 - 2022 (USD Million)
Figure 20 Prostrate cancer market, 2015 - 2022 (USD Million)
Figure 21 Other cancer market, 2015 - 2022 (USD Million)
Figure 22 Tumor ablation market share, by region, 2013 & 2020
Figure 23 North America Tumor ablation market, 2015 - 2022 (USD Million)
Figure 24 U.S. tumor ablation market, 2015 - 2022 (USD Million)
Figure 25 Canada tumor ablation market, 2015 - 2022 (USD Million)
Figure 26 Europe tumor ablation market, 2015 - 2022 (USD Million)
Figure 27 UK tumor ablation market, 2015 - 2022 (USD Million)
Figure 28 Germany tumor ablation market, 2015 - 2022 (USD Million)
Figure 29 Asia Pacific tumor ablation market, 2015 - 2022 (USD Million)
Figure 30 Japan tumor ablation market, 2015 - 2022 (USD Million)
Figure 31 China tumor ablation market, 2015 - 2022 (USD Million)
Figure 32 Latin America tumor ablation market, 2015 - 2022 (USD Million)
Figure 33 Mexico tumor ablation market, 2015 - 2022 (USD Million)
Figure 34 Brazil tumor ablation market, 2015 - 2022 (USD Million)
Figure 35 MEA tumor ablation market, 2015 - 2022 (USD Million)
Figure 36 South Africa tumor ablation market, 2015 - 2022 (USD Million)
Figure 37 Saudi Arabia tumor ablation market, 2015 - 2022 (USD Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll